Arakis Limited

Focuses on discovery and development of inflammatory diseases and oncology adjunctive therapy.

Launch date

2000

Market cap

Enterprise valuation

AUD217m (Public information from Jul 2005)

London England (HQ & founding location)

Date	Investors	Amount	Round
Aug 2000	Alice Ventures Excalibur Fund Managers	£4.0m	Early VC
Apr 2002	Nomura Alice Ventures 3i Group Excalibur Fund Managers	£16.0m	Series B
Sep 2004	Scottish Equity Partners Novo Holdings Novo Seeds	£29.0m	Series C
Jul 2005	Sosei Group	£107m Valuation: £107m	Acquisition
Total Funding		AUD100m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Arakis Limited